Declaration of conflicts of interest in scientific publications

Møller, Henrik

doi:10.1080/15622970802685032

Cited by 3 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In principle, issues related to bias in authorship are framed as a financial or non-financial conflict of interests (COIs). Financial COIs are often explored in parallel with discussions about collaborations between academia and industry, and sponsors' influence on authors' independence (Edwards & Bhopal 1999;McComas 2008;Adams 2009;Moeller 2009;Miller et al 2017). Lack of clear definitions (Patel et al 2011), inadequate guidance on compliance (Rohwer et al 2017), and discrepancies between institutional and national guidelines or between various universities and societies are seen as factors that complicate compliance with guidelines about COI (Hillman et al 1991;Lanken et al 1995;Woteki 2006).…”

Section: -Bias (81 Documents)mentioning

confidence: 99%

A review of the literature on ethical issues related to scientific authorship

Hosseini

Gordijn

2020

Accountability in Research

View full text Add to dashboard Cite

The article at hand presents the results of a literature review on the ethical issues related to scientific authorship. These issues are understood as questions and/or concerns about obligations, values or virtues in relation to reporting, authorship and publication of research results. For this purpose, the Web of Science core collection was searched for English resources published between 1945 and 2018, and a total of 324 items were analyzed. Based on the review of the documents, ten ethical themes have been identified, some of which entail several ethical issues. Ranked on the basis of their frequency of occurrence these themes are: 1) attribution, 2) violations of the norms of authorship, 3) bias, 4) responsibility and accountability, 5) authorship order, 6) citations and referencing, 7) definition of authorship, 8) publication strategy, 9) originality, and 10) sanctions. In mapping these themes, the current article explores major ethical issue and provides a critical discussion about the application of codes of conduct, various understandings of culture, and contributing factors to unethical behavior.

show abstract

Section: -Bias (81 Documents)mentioning

confidence: 99%

A review of the literature on ethical issues related to scientific authorship

Hosseini

Gordijn

2020

Accountability in Research

View full text Add to dashboard Cite

show abstract

Conflicts of Interest

Fava¹

2010

Ethics in Psychiatry

View full text Add to dashboard Cite

Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations

Möller

Maier

2009

Eur Arch Psychiatry Clin Neurosci

View full text Add to dashboard Cite

Psychopharmacotherapy should now be regulated in the sense of evidence-based medicine, as is the case in other areas of clinical treatment in medicine. In general this is a meaningful development, which principally will have a positive impact on routine health care in psychiatry. But several related problems should not be ignored. So far consensus on an internationally accepted evidence graduation could not be reached due to several difficulties related to this. For example, focussing on the results of meta-analyses instead of considering relevant single studies results in a decision-making logic which is in conflict with the rationale applied by drug authorities in the licensing process. Another example is the relevance of placebo-controlled trials: if randomized placebo-controlled phase-III studies are prioritized in the evidence grading, the evidence possibly deviates too far from the conditions of routine clinical care due to the special selection of patients in those studies. However, a grading primarily based on active comparator trials could lead to wrong conclusions about efficacy. This concerns especially the so-called "effectiveness" studies and other forms of phase-IV studies with their less restrictive methodological rigidity. Attempts to regulate psychopharmacotherapy in the sense of evidence-based medicine come closer to their limits the more complex the clinical situation and the respective decision-making logic are. Even in times of evidence-based medicine a large part of complex clinical decision-making in psychopharmacotherapy still relies more on clinical experience and a consensus on clinical experience, traditions and belief systems than on results of efficacy oriented phase-III and effectiveness-oriented phase-IV clinical studies.

show abstract

Declaration of conflicts of interest in scientific publications

Cited by 3 publications

References 14 publications

A review of the literature on ethical issues related to scientific authorship

A review of the literature on ethical issues related to scientific authorship

Conflicts of Interest

Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations

Contact Info

Product

Resources

About